Du Four S - Search Results

1

Pituitary carcinoma - case series and review of the literature.

Du Four S, Van Der Veken J, Duerinck J, Vermeulen E, Andreescu CE, Bruneau M, Neyns B, Velthoven V, Velkeniers B. Du Four S, et al. Front Endocrinol (Lausanne). 2022 Sep 8;13:968692. doi: 10.3389/fendo.2022.968692. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36157469 Free PMC article. Review.

2

Correlation between IDH1 gene mutation status and survival of patients treated for recurrent glioma.

Lv S, Teugels E, Sadones J, Quartier E, Huylebrouck M, DU Four S, LE Mercier M, DE Witte O, Salmon I, Michotte A, DE Grève J, Neyns B. Lv S, et al. Among authors: du four s. Anticancer Res. 2011 Dec;31(12):4457-63. Anticancer Res. 2011. PMID: 22199315

3

Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor.

Wilgenhof S, Morlion V, Seghers AC, Du Four S, Vanderlinden E, Hanon S, Vandenbroucke F, Everaert H, Neyns B. Wilgenhof S, et al. Among authors: du four s. Anticancer Res. 2012 Apr;32(4):1355-9. Anticancer Res. 2012. PMID: 22493370

4

Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies.

Du Four S, Wilgenhof S, Duerinck J, Michotte A, Van Binst A, De Ridder M, Neyns B. Du Four S, et al. Eur J Cancer. 2012 Nov;48(16):3045-51. doi: 10.1016/j.ejca.2012.05.016. Epub 2012 Jun 22. Eur J Cancer. 2012. PMID: 22727601

5

Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab.

Lv S, Teugels E, Sadones J, De Brakeleer S, Duerinck J, Du Four S, Michotte A, De Grève J, Neyns B. Lv S, et al. Among authors: du four s. Int J Oncol. 2012 Sep;41(3):1029-35. doi: 10.3892/ijo.2012.1539. Epub 2012 Jun 29. Int J Oncol. 2012. PMID: 22752145 Clinical Trial.

6

Patterns of response in patients with pretreated metastatic melanoma who received ipilimumab 3 mg/kg in a European expanded access program: five illustrative case reports.

Wilgenhof S, Du Four S, Everaert H, Neyns B. Wilgenhof S, et al. Among authors: du four s. Cancer Invest. 2012 Dec;30(10):712-20. doi: 10.3109/07357907.2012.727934. Epub 2012 Oct 8. Cancer Invest. 2012. PMID: 23043499 Free PMC article.

7

Single-center experience with ipilimumab in an expanded access program for patients with pretreated advanced melanoma.

Wilgenhof S, Du Four S, Vandenbroucke F, Everaert H, Salmon I, Liénard D, Marmol VD, Neyns B. Wilgenhof S, et al. Among authors: du four s. J Immunother. 2013 Apr;36(3):215-22. doi: 10.1097/CJI.0b013e31828eed39. J Immunother. 2013. PMID: 23502769

8

Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients.

Du Four S, Hong A, Chan M, Charakidis M, Duerinck J, Wilgenhof S, Wang W, Feng L, Michotte A, Okera M, Shivalingam B, Fogarty G, Kefford R, Neyns B. Du Four S, et al. Case Rep Oncol Med. 2014;2014:417913. doi: 10.1155/2014/417913. Epub 2014 Jul 1. Case Rep Oncol Med. 2014. PMID: 25105043 Free PMC article.

9

AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells.

Maenhout SK, Du Four S, Corthals J, Neyns B, Thielemans K, Aerts JL. Maenhout SK, et al. Among authors: du four s. Oncotarget. 2014 Aug 30;5(16):6801-15. doi: 10.18632/oncotarget.2254. Oncotarget. 2014. PMID: 25149535 Free PMC article.

10

Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.

Du Four S, Maenhout SK, De Pierre K, Renmans D, Niclou SP, Thielemans K, Neyns B, Aerts JL. Du Four S, et al. Oncoimmunology. 2015 Jan 22;4(4):e998107. doi: 10.1080/2162402X.2014.998107. eCollection 2015 Apr. Oncoimmunology. 2015. PMID: 26137411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page